Bile duct cancer, Biliary tree cancers, Bowel (colorectal) cancer, Gallbladder cancer, Liver cancer
Open
Phase 3
This trial is looking at aspirin to reduce the risk of cancer, liver disease and the need for a liver transplant.
It is for people with both:
primary sclerosing cholangitis
inflammatory bowel disease (IBD)
Cancer Research UK supports this trial.
Recruitment start: 26 March 2024
Recruitment end: 31 March 2029
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Shahid Khan and Dr Simon Rushbrook
Cancer Research UK
Imperial College London
This is Cancer Research UK trial number CRUK/22/010
Last reviewed: 13 May 2025
CRUK internal database number: 19804
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
